Genmab (NASDAQ:GMAB) just reported results for the first quarter of 2024.
- Genmab reported earnings per share of 29 cents. This was above the analyst estimate for EPS of 14 cents.
- The company reported revenue of $600.44 million.
- This was 3.98% better than the analyst estimate for revenue of $577.46 million.